The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

Arthritis Research and Therapy

Volumn 9, Issue 5, 2007, Pages

  Han, Chenglong ^a   Smolen, Josef S ^b   Kavanaugh, Arthur ^c   van der Heijde, Désirée ^d   Braun, Jürgen ^e   Westhovens, René ^f   Zhao, Ning ^a   Rahman, Mahboob U ^a   Baker, Daniel ^a   Bala, Mohan ^a  

^a CENTOCOR INC   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RHEUMAZENTRUM RUHRGEBIET   (Germany)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE; PLACEBO; MONOCLONAL ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SHORT FORM 36; ADOLESCENT; AGED; COHORT ANALYSIS; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT; RHEUMATIC DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; QUALITY OF LIFE; RHEUMATIC DISEASES; TREATMENT OUTCOME;

EID: 37249056988     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2306     Document Type: Article

References (14)

1. Gladman DD Antoni C Mease P Clegg DO Nash P Psoriatic arthritis: epidemiology, clinical features, course, and outcome Ann Rheum Dis 2005, 64(Suppl 2):iI14-17. 10.1136/ard.2004.032482 15708927
2. Wolfe F Hawley DJ The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 year study of 823 patients J Rheumatol 1998, 25:2108-2117. 9818651
3. Chorus AM Miedema HS Boonen A Van Der Linden S Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age Ann Rheum Dis 2003, 62:1178-1184. 1754383 14644855 10.1136/ ard.2002.004861
4. Husted JA Gladman DD Farewell VT Cook RJ Health-related quality of life of patients with psoriatic arthritis: A comparison with patients with rheumatoid arthritis Arthritis Rheum 2001, 45:151-158. 10.1002/ 1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T 11324779
5. Maini R St Clair EW Breedveld F Furst D Kalden J Weisman M Smolen J Emery P Harriman G Feldmann M Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group Lancet 1999, 354:1932-1939. 10.1016/ S0140-6736(99)05246-0 10622295
6. Lipsky PE van der Heijde DM St Clair EW Furst DE Breedveld FC Kalden JR Smolen JS Weisman M Emery P Feldmann M Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group N Engl J Med 2000, 343:1594-1602. 10.1056/NEJM200011303432202 11096166
7. Maini RN Breedveld FC Kalden JR Smolen JS Furst D Weisman MH St Clair EW Keenan GF van der Heijde D Marsters PA Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate Arthritis Rheum 2004, 50:1051-1065. 10.1002/art.20159 15077287
8. Westhovens R Yocum D Han J Berman A Strusberg I Geusens P Rahman MU The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: A large, randomized, placebo-controlled trial Arthritis Rheum 2006, 54:1075-1086. 10.1002/art.21734 16572442
9. van der Heijde D Dijkmans B Geusens P Sieper J DeWoody K Williamson P Braun J Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT) Arthritis Rheum 2005, 52:582-591. 10.1002/art.20852 15692973
10. Antoni C Krueger GG de Vlam K Birbara C Beutler A Guzzo C Zhou B Dooley LT Kavanaugh A Infliximab improves signs and symptoms of psoriatic arthritis: Results of the IMPACT 2 trial Ann Rheum Dis 2005, 64:1150-1157. 10.1136/ard.2004.032268 15677701
11. Kavanaugh A Antoni C Krueger GG Yan S Bala M Dooley LT Beutler A Guzzo C Gladman D Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis Ann Rheum Dis 2006, 65:471-477. 10.1136/ard.2005.040196 16096330
12. Hedges LV Olkin I Statistical Methods for Meta-Analysis New York: Academic Press 1985
13. Samsa G Edelman D Rothman ML Williams GR Lipscomb J Matchar D Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II Pharmacoeconomics 1999, 15:141-155. 10.2165/00019053-199915020-00003 10351188
14. Ware JE Jr Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002 1593914